Brief: Fulgent Genetics Agrees To Acquire Inform Diagnostics And Provides Preliminary First Quarter Revenue Results
18/04/2022 21:40
April 18 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS AGREES TO ACQUIRE INFORM DIAGNOSTICS AND
PROVIDES PRELIMINARY FIRST QUARTER REVENUE RESULTS
* SEES Q1 REVENUE ABOUT $300 MILLION
* DEAL FOR APPROXIMATELY $170 MILLION
* FULGENT - UPDATES FULL YEAR 2022 CORE REVENUE GUIDANCE TO
APPROXIMATELY $175 MILLION INCLUDING POTENTIAL REVENUE
CONTRIBUTION FROM PROPOSED ACQUISITION
Source text for Eikon: ID:nBwbkrD5Sa
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview